XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Apr. 30, 2022
Apr. 24, 2021
Apr. 25, 2020
Cash flows from operating activities      
Net income $ 152,328 $ 107,529 $ 78,984
Adjustments to reconcile net income to cash provided by operating activities      
(Gain)/loss on disposal of assets (13,657) (37) (10,068)
Gain on sale of investments (478) (954) (693)
Provision for doubtful accounts (617) (3,169) 13,383
Depreciation and amortization 39,771 33,021 31,192
Amortization of right-of-use lease assets 72,942 65,571 67,673
Equity-based compensation expense 11,858 12,671 8,371
Goodwill impairment 0 0 26,862
Pension termination refund 0 0 (1,900)
Change in deferred taxes 1,022 8,790 719
Change in receivables (41,829) (38,288) 29,686
Change in inventories (72,022) (40,727) 14,900
Change in other assets (16,232) 2,926 7,039
Change in payables 6,326 37,068 (9,913)
Change in lease liabilities (73,805) (65,881) (66,238)
Change in other liabilities 13,397 191,397 (25,755)
Net cash provided by operating activities 79,004 309,917 164,242
Cash flows from investing activities      
Proceeds from disposals of assets 22,588 2,770 11,273
Proceeds from insurance 0 0 1,080
Capital expenditures (76,580) (37,960) (46,035)
Purchases of investments (34,152) (39,584) (37,477)
Proceeds from sales of investments 36,096 36,071 37,244
Acquisitions (26,323) (2,000) 0
Net cash used for investing activities (78,371) (40,703) (33,915)
Cash flows from financing activities      
Net proceeds from credit facility 0 0 75,000
Payments on debt and finance lease liabilities (121) (75,050) (161)
Holdback payments for acquisition purchases (23,000) (5,783) (6,850)
Stock issued for stock and employee benefit plans, net of shares withheld for taxes (1,818) 9,030 3,029
Repurchases of common stock (90,645) (44,202) (43,369)
Dividends paid to shareholders (27,717) (16,542) (25,091)
Dividends paid to minority interest joint venture partners [1] (1,260) (8,507) 0
Net cash used for financing activities (144,561) (141,054) 2,558
Effect of exchange rate changes on cash and equivalents (1,919) 3,015 (1,144)
Change in cash, cash equivalents and restricted cash (145,847) 131,175 131,741
Cash, cash equivalents and restricted cash at beginning of period 394,703 263,528 131,787
Cash, cash equivalents and restricted cash at end of period 248,856 394,703 263,528
Supplemental disclosure of non-cash investing activities      
Capital expenditures included in accounts payable $ 9,234 $ 4,638 $ 3,528
[1] Includes dividends paid to joint venture minority partners resulting from the repatriation of dividends from our foreign earnings that we no longer consider permanently reinvested.